Cargando…

Transcriptomic Analysis of Liver Indicates Novel Vaccine to Porcine Reproductive and Respiratory Virus Promotes Homeostasis in T-Cell and Inflammatory Immune Responses Compared to a Commercial Vaccine in Pigs

One of the largest impediments for commercial swine production is the presence of Porcine Reproductive and Respiratory Syndrome Virus (PRRSV), a devastating RNA viral infection that is responsible for over $1 billion in loss in the U.S. annually. The challenge with combating PRRSV is a combination o...

Descripción completa

Detalles Bibliográficos
Autores principales: Fleming, Damarius S., Miller, Laura C., Li, Jiuyi, Van Geelen, Albert, Sang, Yongming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987227/
https://www.ncbi.nlm.nih.gov/pubmed/35400088
http://dx.doi.org/10.3389/fvets.2022.791034
_version_ 1784682693842173952
author Fleming, Damarius S.
Miller, Laura C.
Li, Jiuyi
Van Geelen, Albert
Sang, Yongming
author_facet Fleming, Damarius S.
Miller, Laura C.
Li, Jiuyi
Van Geelen, Albert
Sang, Yongming
author_sort Fleming, Damarius S.
collection PubMed
description One of the largest impediments for commercial swine production is the presence of Porcine Reproductive and Respiratory Syndrome Virus (PRRSV), a devastating RNA viral infection that is responsible for over $1 billion in loss in the U.S. annually. The challenge with combating PRRSV is a combination of the effect of an extraordinary rate of mutation, the ability to infect macrophages, and subversion of host immune response through a series of actions leading to both immunomodulation and immune evasion. Currently there are a handful of commercial vaccines on the market that have been shown to be effective against homologous infections, but struggle against heterologous or mixed strain infections. However, vaccination is the current best strategy for combating PRRSV, making research into new vaccine technology key. To address these issues with PRRSV and host antiviral functions a novel modified-live vaccine (MLV) able to stimulate known antiviral interferons was created and examined for its ability to potentiate effective immunity and better protection. Here, we examine gene expression in the liver of pigs vaccinated with our novel vaccine, given the liver's large role in antiviral responses and vaccine metabolism. Our study indicated that pigs administered the novel vaccine experience homeostatic gene expression consistent with less inflammation and T-cell depletion risk than pigs administered the commercial vaccine.
format Online
Article
Text
id pubmed-8987227
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-89872272022-04-08 Transcriptomic Analysis of Liver Indicates Novel Vaccine to Porcine Reproductive and Respiratory Virus Promotes Homeostasis in T-Cell and Inflammatory Immune Responses Compared to a Commercial Vaccine in Pigs Fleming, Damarius S. Miller, Laura C. Li, Jiuyi Van Geelen, Albert Sang, Yongming Front Vet Sci Veterinary Science One of the largest impediments for commercial swine production is the presence of Porcine Reproductive and Respiratory Syndrome Virus (PRRSV), a devastating RNA viral infection that is responsible for over $1 billion in loss in the U.S. annually. The challenge with combating PRRSV is a combination of the effect of an extraordinary rate of mutation, the ability to infect macrophages, and subversion of host immune response through a series of actions leading to both immunomodulation and immune evasion. Currently there are a handful of commercial vaccines on the market that have been shown to be effective against homologous infections, but struggle against heterologous or mixed strain infections. However, vaccination is the current best strategy for combating PRRSV, making research into new vaccine technology key. To address these issues with PRRSV and host antiviral functions a novel modified-live vaccine (MLV) able to stimulate known antiviral interferons was created and examined for its ability to potentiate effective immunity and better protection. Here, we examine gene expression in the liver of pigs vaccinated with our novel vaccine, given the liver's large role in antiviral responses and vaccine metabolism. Our study indicated that pigs administered the novel vaccine experience homeostatic gene expression consistent with less inflammation and T-cell depletion risk than pigs administered the commercial vaccine. Frontiers Media S.A. 2022-03-24 /pmc/articles/PMC8987227/ /pubmed/35400088 http://dx.doi.org/10.3389/fvets.2022.791034 Text en Copyright © 2022 Fleming, Miller, Li, Van Geelen and Sang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Veterinary Science
Fleming, Damarius S.
Miller, Laura C.
Li, Jiuyi
Van Geelen, Albert
Sang, Yongming
Transcriptomic Analysis of Liver Indicates Novel Vaccine to Porcine Reproductive and Respiratory Virus Promotes Homeostasis in T-Cell and Inflammatory Immune Responses Compared to a Commercial Vaccine in Pigs
title Transcriptomic Analysis of Liver Indicates Novel Vaccine to Porcine Reproductive and Respiratory Virus Promotes Homeostasis in T-Cell and Inflammatory Immune Responses Compared to a Commercial Vaccine in Pigs
title_full Transcriptomic Analysis of Liver Indicates Novel Vaccine to Porcine Reproductive and Respiratory Virus Promotes Homeostasis in T-Cell and Inflammatory Immune Responses Compared to a Commercial Vaccine in Pigs
title_fullStr Transcriptomic Analysis of Liver Indicates Novel Vaccine to Porcine Reproductive and Respiratory Virus Promotes Homeostasis in T-Cell and Inflammatory Immune Responses Compared to a Commercial Vaccine in Pigs
title_full_unstemmed Transcriptomic Analysis of Liver Indicates Novel Vaccine to Porcine Reproductive and Respiratory Virus Promotes Homeostasis in T-Cell and Inflammatory Immune Responses Compared to a Commercial Vaccine in Pigs
title_short Transcriptomic Analysis of Liver Indicates Novel Vaccine to Porcine Reproductive and Respiratory Virus Promotes Homeostasis in T-Cell and Inflammatory Immune Responses Compared to a Commercial Vaccine in Pigs
title_sort transcriptomic analysis of liver indicates novel vaccine to porcine reproductive and respiratory virus promotes homeostasis in t-cell and inflammatory immune responses compared to a commercial vaccine in pigs
topic Veterinary Science
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987227/
https://www.ncbi.nlm.nih.gov/pubmed/35400088
http://dx.doi.org/10.3389/fvets.2022.791034
work_keys_str_mv AT flemingdamariuss transcriptomicanalysisofliverindicatesnovelvaccinetoporcinereproductiveandrespiratoryviruspromoteshomeostasisintcellandinflammatoryimmuneresponsescomparedtoacommercialvaccineinpigs
AT millerlaurac transcriptomicanalysisofliverindicatesnovelvaccinetoporcinereproductiveandrespiratoryviruspromoteshomeostasisintcellandinflammatoryimmuneresponsescomparedtoacommercialvaccineinpigs
AT lijiuyi transcriptomicanalysisofliverindicatesnovelvaccinetoporcinereproductiveandrespiratoryviruspromoteshomeostasisintcellandinflammatoryimmuneresponsescomparedtoacommercialvaccineinpigs
AT vangeelenalbert transcriptomicanalysisofliverindicatesnovelvaccinetoporcinereproductiveandrespiratoryviruspromoteshomeostasisintcellandinflammatoryimmuneresponsescomparedtoacommercialvaccineinpigs
AT sangyongming transcriptomicanalysisofliverindicatesnovelvaccinetoporcinereproductiveandrespiratoryviruspromoteshomeostasisintcellandinflammatoryimmuneresponsescomparedtoacommercialvaccineinpigs